FindTrial
Sign In

Event related potentials of transcranial magnetic stimulation combined with antidepressants in the treatment of major depressive disorder

Event related potentials of transcranial magnetic stimulation combined with antidepressants in the treatment of major depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009672
Enrollment
Unknown
Registered
2016-10-27
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

rTMS plus drug:rTMS plus drug
Drug only:Drug only

Sponsors

Department of Neurobiological Examine Centre, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Major depression disorder (MDD) patients must be in first episode or drug-nave (have at least 3-month free of antidepressant treatment). All MDD patients were right-handed, normal hearing and Han nationality; Aged 18 years and elder, DSM IV criteria for MDD, 24-item Hamilton Rating Scale for Depression (HAMD, Chinese edition)=17.

Exclusion criteria

Exclusion criteria: People with other physical or mental disorder, treated with ECT or rTMS in the last one year, epilepsy, pregnancy or any other issues that cannot be getting into a high magnetic situation.

Design outcomes

Primary

MeasureTime frame
Miss match negative;P300;Sensory gating P50;Hamilton Rating Scale for Depression;Hamilton Rating Scale for Anxiety;—

Countries

China

Contacts

Public ContactZhong Zheng

Department of Neurobiological Examine Centre, West China Hospital, Sichuan University , Chengdu 610000, P.R. China

zhengzhong1963@qq.com+86 18980601861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026